Screener
BioLife Solutions BLFS Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by BioLife Solutions in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The source filing: BioLife Solutions’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:22 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054355
| (In thousands, except per share and share data) | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $23,997 | $33,038 |
| Available-for-sale securities, current portion | 58,419 | 55,889 |
| Accounts receivable, trade, net of allowance for credit losses of $16 and $22 as of June 30, 2026 and December 31, 2025, respectively | 10,652 | 7,953 |
| Inventories | 35,591 | 30,155 |
| Prepaid expenses and other current assets | 6,539 | 9,526 |
| Total current assets | 135,198 | 136,561 |
Item 1. Unaudited Condensed Consolidated Financial Statements
FAQ
- What is BioLife Solutions's short-term investments?
- BioLife Solutions (BLFS) reported short-term investments of $58.42M in Q2 2026.
- How has BioLife Solutions's short-term investments changed year-over-year?
- BioLife Solutions's short-term investments increased by 17.2% year-over-year, from $49.86M to $58.42M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about BioLife Solutions's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude